Protocol summary

Study aim
Comparison of two very low doses of naloxone in combination with ropivacaine on the onset ,severity and duration of axillary block in patients with hand and forearm surgery
Design
Clinical trial with control group, parallel groups, double-blind, randomized, phase 3 on 75 patients. In order to randomize, the block randomization method will be used.
Settings and conduct
In this research, all patients requiring hand and forearm surgery, referred to Rasoul Akram Hospital in Tehran, will be included in the study. Patients will be randomly divided into 3 groups based on blocks of 6. The sample size for each study group is 20 people. A total of 60 patients will be examined. Patients, surgeon and data analyst will be blinded.
Participants/Inclusion and exclusion criteria
Inclusion criteria: Candidate patients for hand and forearm surgery, Age between 18-70 years. Exclusion criteria: Anemia, sensitivity to local anesthetic drugs, congenital and acquired neuromuscular diseases, history of seizures, drug addiction, heart diseases and any digestive system disorders.
Intervention groups
Patients are divided into three groups of 20 and undergo axillary block guided by ultrasound and neurostimulator. In the first intervention group, axillary block is performed using ropivacaine in combination with naloxone 4 micrograms. In the second intervention group, axillary block is performed using ropivacaine combined with naloxone 0.4 micrograms. In the control group, axillary block is performed using ropivacaine combined with normal saline (placebo).
Main outcome variables
Pain score; The amount of drug use

General information

Reason for update
Acronym
IRCT registration information
IRCT registration number: IRCT20170105031787N6
Registration date: 2023-05-03, 1402/02/13
Registration timing: prospective

Last update: 2023-05-03, 1402/02/13
Update count: 0
Registration date
2023-05-03, 1402/02/13
Registrant information
Name
Mohammad-Reza Yasinzadeh
Name of organization / entity
Iran university of medical sience
Country
Iran (Islamic Republic of)
Phone
+98 21 6652 5327
Email address
yasinzadeh.mr@iums.ac.ir
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2023-05-22, 1402/03/01
Expected recruitment end date
2023-11-21, 1402/08/30
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Comparison of two very low doses of naloxone in combination with ropivacaine on the onset ,severity and duration of axillary block in patients with hand and forearm surgery
Public title
Two very low doses of naloxone in combination with ropivacaine on the onset ,severity and duration of axillary block
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
Candidate patients for hand and forearm surgery Age between 18-70 years
Exclusion criteria:
Anemia Sensitivity to local anesthetic drugs Congenital and acquired neuromuscular diseases History of seizures Drug addiction Heart diseases Any digestive system disorders.
Age
From 18 years old to 70 years old
Gender
Both
Phase
3
Groups that have been masked
  • Participant
  • Investigator
  • Outcome assessor
  • Data analyser
Sample size
Target sample size: 60
Randomization (investigator's opinion)
Randomized
Randomization description
Patients will be randomly divided into 3 groups. The randomization tool will be a random sequence generation software called SIS. In addition to simple randomization, these random sequence generation softwares are capable of generating random sequences using the block method. Block randomization method will be used for randomization. Block randomization is for the purpose of making sure that exactly equal number of participants enter the study groups. The advantages of block randomization are that the balance of the number of participants in each group is guaranteed. For this purpose, 6 blocks will be formed and in each block 2 people from intervention group 1, 2 people from intervention group 2 and 2 people will be placed in the control group. A total of 10 blocks will be considered to reach the sample size. Random allocation concealment will be done using opaque envelopes sealed with a random sequence, in this method, each of the random sequences created is recorded on a card and the cards are placed inside the envelopes in order. In order to maintain a random sequence, the envelopes are numbered in the same way on the outer surface. Finally, the letter envelopes are glued and placed in a box, respectively. the door At the beginning of the registration of participants, based on the order of entry of eligible participants into the study, one of the envelopes of the letter is opened in order and the assigned group of the participant is revealed.
Blinding (investigator's opinion)
Double blinded
Blinding description
The surgeon and the patients will be unaware and blind of the type of drug used in the axillary block. To hide similar and identical sera, it was used without drug name label and only with code. Patients will be aware that they will be randomly assigned to one of three treatment groups, but will not know which treatment will be provided in that group. Patients will be assigned to one of three groups using a random number table. The surgeon also knows that axillary block will be performed by three different methods for the patients, but he will not know which method will be performed for each patient. The person in charge of data collection, the analyst, and the outcome evaluator will collect and analyze the information based on groups 1, 2, and 3, and will not know the type of treatment provided in the groups and will be kept blind.
Placebo
Used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Ethics committee of Iran University of Medical Sciences
Street address
Iran University of Medical Sciences, Hemmat Highway
City
Tehran
Province
Tehran
Postal code
1449614535
Approval date
2023-01-04, 1401/10/14
Ethics committee reference number
IR.IUMS.FMD.REC.1401.498

Health conditions studied

1

Description of health condition studied
hand and forearm surgery
ICD-10 code
S50-S59
ICD-10 code description
Injuries to the elbow and forearm

Primary outcomes

1

Description
Pain score
Timepoint
Upon entering recovery
Method of measurement
Based on NRS scale

2

Description
The amount of drug use
Timepoint
In the first 24 hours after the surgery
Method of measurement
Based on the information in the patient's file

Secondary outcomes

1

Description
Duration of numbness
Timepoint
During surgery
Method of measurement
Based on the information in the patient's file

2

Description
The first time to ask for drugs
Timepoint
During surgery
Method of measurement
Based on the information in the patient's file

3

Description
Ramsy sedation scale
Timepoint
During surgery and upon entering recovery
Method of measurement
Based on the information in the patient's file

4

Description
Patient's satisfaction
Timepoint
After surgery
Method of measurement
Based on the Likert scale

Intervention groups

1

Description
Intervention group 1: The axillary block will be performed using 29 cc of ropivacaine 0.5% (manufacturer: Varian Pharmamed) plus 1 cc of naloxone 4 micrograms (manufacturer: Tolid Daroo).
Category
Treatment - Drugs

2

Description
Intervention group 2: The axillary block will be performed using 29 cc of ropivacaine 0.5% (manufacturer: Varian Pharmamed) plus 1 cc of naloxone 0.4 micrograms (manufacturer: Tolid Daroo).
Category
Treatment - Drugs

3

Description
Control group: The axillary block will be performed using 29 cc of ropivacaine 0.5% (manufacturer: Varian Pharmamed) plus 1 cc of normal saline (30 cc in total).
Category
Treatment - Drugs

Recruitment centers

1

Recruitment center
Name of recruitment center
Rasoul-Akram Hospital
Full name of responsible person
Mahshad Ghezel Bash
Street address
Rasoul-Akram Hospital, Niayesh St., Sattarkahn Ave
City
Tehran
Province
Tehran
Postal code
1445613131
Phone
+98 21 6435 2222
Email
Rasoolhospital@iums.ac.ir

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Iran University of Medical Sciences
Full name of responsible person
Hossein Keyvani
Street address
Iran University of Medical Sciences, Hemmat Highway
City
Tehran
Province
Tehran
Postal code
1449614535
Phone
+98 21 8670 2503
Email
research@iums.ac.ir
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Iran University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic

Person responsible for general inquiries

Contact
Name of organization / entity
Iran University of Medical Sciences
Full name of responsible person
Mahshad Ghezel Bash
Position
Resident
Latest degree
Medical doctor
Other areas of specialty/work
Anesthesiology
Street address
Rasoul-Akram Hospital, Niayesh St., Sattarkahn Ave
City
Tehran
Province
Tehran
Postal code
1445613131
Phone
+98 21 6435 2491
Email
Mahshad.ghezelbash@gmail.com

Person responsible for scientific inquiries

Contact
Name of organization / entity
Iran University of Medical Sciences
Full name of responsible person
Mahshad Ghezel Bash
Position
Resident
Latest degree
Medical doctor
Other areas of specialty/work
Anesthesiology
Street address
Rasoul-Akram Hospital, Niayesh St., Sattarkahn Ave
City
Tehran
Province
Tehran
Postal code
1445613131
Phone
+98 21 6435 2491
Email
Mahshad.ghezelbash@gmail.com

Person responsible for updating data

Contact
Name of organization / entity
Iran University of Medical Sciences
Full name of responsible person
Mahshad Ghezel Bash
Position
Resident
Latest degree
Medical doctor
Other areas of specialty/work
Anesthesiology
Street address
Rasoul-Akram Hospital, Niayesh St., Sattarkahn Ave
City
Tehran
Province
Tehran
Postal code
1445613131
Phone
+98 21 6435 2491
Email
Mahshad.ghezelbash@gmail.com

Sharing plan

Deidentified Individual Participant Data Set (IPD)
Undecided - It is not yet known if there will be a plan to make this available
Study Protocol
Undecided - It is not yet known if there will be a plan to make this available
Statistical Analysis Plan
Undecided - It is not yet known if there will be a plan to make this available
Informed Consent Form
Undecided - It is not yet known if there will be a plan to make this available
Clinical Study Report
Undecided - It is not yet known if there will be a plan to make this available
Analytic Code
Undecided - It is not yet known if there will be a plan to make this available
Data Dictionary
Undecided - It is not yet known if there will be a plan to make this available
Loading...